Shuji Ogino, MD, PhD, MS

Department of Pathology, Brigham & Women's Hospital
Boston, Massachusetts

Shuji Ogino

Shuji Ogino, MD, PhD, MS, is the founding Chief of Molecular Pathological Epidemiology (MPE) Program, Brigham and Women’s Hospital; Professor of Pathology, Harvard Medical School; Professor (Epidemiology), Harvard T.H. Chan School of Public Health; Associate Member of Broad Institute of MIT and Harvard. Dr. Ogino established the International Molecular Pathological Epidemiology (MPE) Meeting Series ( in 2013 and has been serving as its Chair/Co-Chair. He has been recognized as a leading investigator in the integrative science of MPE, to study the interactive roles of environment (i.e., the exposome), microbiome, and immunity in cancer biology.

He conducts multifaceted MPE studies using large-scale prospective cohort studies and clinical trials, having discovered the etiological links between diet and microbiota / immune cell infiltrates in tumors. To standardize nomenclature of gene products including mutant forms, Dr. Ogino established the Gene Product Nomenclature Consortium (GPNC) and has been serving its Chair. With this capacity, he has been a member of the Nomenclature Committee of International Union of Biochemistry and Molecular Biology (IUBMB). For his unique transdisciplinary scientific contribution, Dr. Ogino has received numerous awards and honors.